Contrast-enhanced harmonic endoscopic ultrasonography with time–intensity curve analysis for intraductal papillary mucinous neoplasms of the pancreas

Background and study aims: Preoperative diagnosis of the pathological grade of intraductal papillary mucinous neoplasms (IPMNs) is difficult. This study aimed to evaluate the accuracy of contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS) with time – intensity curve analysis in differentiating between low or intermediate grade dysplasia (LGD/IGD) and high grade dysplasia or invasive carcinoma (HGD/invasive carcinoma) in IPMNs and to assess correlation between the time – intensity curve parameters and tumor microvessel density.

Patients and methods: Data from 30 patients with resected IPMNs (14 LGD/IGD, 16 HGD/invasive carcinoma) who underwent CH-EUS with time – intensity curve analysis were evaluated retrospectively. Time – intensity curve parameters and the microvessel density of the mural nodule were compared between the HGD/invasive carcinoma and LGD/IGD groups; the diagnostic accuracy of the time – intensity curve parameters was evaluated.

Results: The echo intensity change and echo intensity reduction rate of the mural nodule, and the nodule/pancreatic parenchyma contrast ratio were significantly higher in the HGD/invasive carcinoma group than in the LGD/IGD group (P < 0.05); the accuracies of these parameters were 80 %, 86.7 %, and 93.3 %, respectively. The microvessel density of the mural nodule was significantly higher in the HGD/invasive carcinoma group (P = 0.002). There was a strong positive, linear correlation between the echo intensity change of the mural nodule and the microvessel density (r = 0.803, P < 0.001).

Conclusions: CH-EUS with time – intensity curve analysis is potentially useful for quantitatively evaluating the blood flow of IPMN microvasculature, and for differentiating between HGD/invasive carcinoma and LGD/IGD.

• References

• 1 D’Angelica M, Brennan MF, Suriawinata AA et al. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg 2004; 239: 400-408
• 2 Nakagohri T, Kinoshita T, Konishi M et al. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas. Ann Surg Oncol 2007; 14: 3174-3180
• 3 Maire F, Hammel P, Terris B et al. Prognosis of malignant intraductal papillary mucinous tumors of the pancreas after surgical resection: comparison with pancreatic ductal adenocarcinoma. Gut 2002; 51: 717-722
• 4 Correa-Gallego C, Do R, Lefemina J et al. Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram. Ann Surg Oncol 2013; 20: 4348-4355
• 5 Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-364
• 6 van der Zee JA, van Eijck CH, Hop WC et al. Angiogenesis: a prognostic determinant in pancreatic cancer?. Eur J Cancer 2011; 47: 2576-2584
• 7 Yoshitomi H, Kobayashi S, Ohtsuka M et al. Specific expression of endoglin (CD105) in endothelial cells of intratumoral blood and lymphatic vessels in pancreatic cancer. Pancreas 2008; 37: 275-281
• 8 Tachezy M, Reichelt U, Melenberg T et al. Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Histol Histopathol 2010; 25: 1239-1246
• 9 Ohno E, Hirooka Y, Itoh A et al. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasonography findings of mural nodules. Ann Surg 2009; 249: 628-634
• 10 Kitano M, Kudo M, Yamao K et al. Characterization of small solid tumors in the pancreas: the value of contrast-enhanced harmonic endoscopic ultrasonography. Am J Gastroenterol 2012; 107: 303-310
• 11 Napoleon B, Alvarez-Sanchez MV, Gincoul R et al. Contrast-enhanced harmonic endoscopic ultrasound in solid lesions of the pancreas: results of a pilot study. Endoscopy 2010; 42: 564-470
• 12 Gincul R, Palazzo M, Pujol B et al. Contrast-harmonic endoscopic ultrasound for the diagnosis of pancreatic adenocarcinoma: a prospective multicenter trial. Endoscopy 2014; 46: 373-379
• 13 Matsubara H, Itoh A, Kawashima H et al. Dynamic quantitative evaluation of contrast-enhanced endoscopic ultrasonography in the diagnosis of pancreatic disease. Pancreas 2011; 40: 1073-1079
• 14 Bossuyt PM, Reitsma JB, Bruns DE et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin Chem 2003; 49: 1-6
• 15 Tanaka M, Carlos F, Volkan A et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012; 12: 183-197
• 16 Guo J 1, Higashi K, Ueda Y et al. Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas. J Nucl Med 2006; 47: 419-425
• 17 Yamaguchi T, Shirai Y, Ishihara T et al. Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas. Cancer 2005; 104: 2830-2836
• 18 Paris SA, Attasaranya S, Leblanc JK et al. Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: correlation with surgical histopathology. Clin Gastroenterol Hepatol 2007; 5: 489-495
• 19 Frossard JL, Amouyal P, Amouyal G et al. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am J Gastroenterol 2003; 98: 1516-1524
• 20 Marie F, Voitot H, Aubert A et al. Intraductal papillary mucinous neoplasms of the pancreas: performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. Am J Gastroenterol 2008; 103: 2871-2877
• 21 Lim LG, Lakhtakia S, Ang TL et al. Factors determining diagnostic yield of endoscopic ultrasound guided fine-needle aspiration for pancreatic cystic lesions: a multicenter Asian study. Dig Dis Sci 2013; 58: 1751-1757
• 22 Thornton GD, McPhail MJ, Nayagam S et al. Endoscopic ultrasound guided fine needle aspiration for the diagnosis of pancreatic cystic neoplasms: a meta-analysis. Pancreatology 2013; 13: 48-57
• 23 Ohno E, Itoh A, Kawashima H et al. Malignant transformation of branch-duct type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes. Pancreas 2012; 41: 855-862
• 24 Lee JH, Lee KT, Park J et al. Predictive factors associated with malignancy of intraductal papillary mucinous pancreatic neoplasms. World J Gastroenterol 2010; 16: 5353-5358
• 25 Ohtsuka T, Kono H, Nagayoshi Y et al. An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas. Surgery 2012; 151: 76-83
• 26 Itoh T, Hirooka Y, Itoh A et al. Usefulness of contrast-enhanced transabdominal ultrasonography in the diagnosis of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 2005; 100: 144-152
• 27 Uehara H, Ishikawa O, Katayama K et al. Size of mural nodule as an indicator of surgery for branch duct intraductal papillary mucinous neoplasm of the pancreas during follow-up. J Gastroenterol 2011; 46: 657-663
• 28 Zhuang H, Yang ZG, Chen HJ et al. Time-intensity curve parameters in colorectal tumours measured using double contrast-enhanced ultrasound: correlations with tumour angiogenesis. Colorectal Dis 2012; 14: 181-187
• 29 Kuehn R, Lelkes PI, Bloechle C et al. Angiogenesis, angiogenic growth factors, and cell adhesion molecules are upregulated in chronic pancreatic disease: angiogenesis in chronic pancreatitis and in pancreatic cancer. Pancreas 1999; 18: 96-103
• 30 Banerjee SK, Zoubine MN, Mullick M et al. Tumor angiogenesis in chronic pancreatitis and pancreatic adenocarcinoma: impact of K-ras mutations. Pancreas 2000; 20: 248-255